Top Articles

The objective of this parallel, double-masked, randomized, phase IIb clinical trial, was to evaluate the safety and efficacy of 2 chloroquine diphosphate (CQ) dosages in patients with severe COVID-19. 81 adult patients who were hospitalized with SARS-CoV-2 infection were enrolled from March 23 to April 5, 2020, at a tertiary care facility in Manaus, Brazilian Amazon.

In this paper recently published in Movement Disorders, Prasad et al., surveyed the perceptions of 100 patients with Parkinson’s disease (PD) and their caregivers who were under follow-up at the National Institute of Mental Health and Neurosciences, Bengaluru, India on the implications of Covid-19 infection.

In this paper recently published in Movement Disorders, Antonini et al., report the outcome of 10 clinical cases of Parkinson’s Disease patients infected by SARS-CoV-2, collected from the experience at the Parkinson and Movement Disorders Unit in Padua, Italy and the Parkinson’s Foundation Centre of Excellence at King’s College Hospital in London, UK.

In this special report recently published in Stroke, Smith et al., assembled a multidisciplinary working group to develop consensus-based recommendations and an algorithm for evaluation and treatment of acute stroke patients eligible for endovascular therapy (EVT) during the COVID-19 pandemic, with the goal of minimizing the negative impact of COVID-19 on acute stroke patients and healthcare providers.

In this paper recently published in the Journal of Neurology, Neurosurgery, and Psychiatry, the authors describe the demographic, clinical, radiological and laboratory characteristics of six consecutive patients assessed between 1st and 16th April 2020 at the National Hospital for Neurology and Neurosurgery, Queen Square, London, UK

In this paper recently published in The New England Journal of Medicine, Oxley et al., report five cases of large-vessel stroke in patients younger than 50 years of age affected by SARS-CoV-2 infection.

I am Nina Khizanishvili, a young neurologist from Tbilisi, Georgia. I currently work in Germany but I still get a lot of information about the situation in the First University Clinic of Tbilisi State Medical University in my home country.

For 2020, we have selected: Shahnawaz M, Mukherjee A, Pritzkow S et al. Discriminating α-synuclein strains in Parkinson’s disease and multiple system atrophy.

As any place in Europe and beyond, the French health system is still under pressure and Covid-19 has already and will profoundly change healthcare.

Despite some positive slowing of new cases and deaths in some countries, the COVID-19 pandemic has infected until today over 3.5 million people, leading to more than 250,000 deaths across the globe. Without a doubt, the crisis sparked by this pandemic has also wreaked havoc on healthcare systems and economies while causing massive disruption to the everyday lives of people around the world.

France is a country of tradition and innovation: France was a pioneer country in Neurology since the 19th century, with seminal clinical and pathological description of many neurological diseases by Charcot (1825-1893) in Salpêtriere hospital in Paris and his colleagues, illustrated by the famous painting by Brouillet “a clinical lesson at the Salpêtriere”.

It is our great pleasure to inform you that the 6th EAN Congress and first Virtual Congress has reached more than 13,000 registered participants!

In this very useful paper, the European Society of Minimally Invasive Neurological Therapy (ESMINT) gives recommendations for optimal interventional neurovascular management during the covid-19 outbreak. The authors identify some important priorities including: early detection and limiting exposure of healthcare workers… Continue Reading

In this interesting correspondence just published in the Lancet, Varga et al. demonstrate endothelial cell involvement across vascular beds of different organs in a series of patients with COVID-19 finding evidence of direct viral infection of the endothelial cell and… Continue Reading

The aim of this multicenter retrospective study, just published in Epilepsia, was to clarify the incidence and risk of acute symptomatic seizures in people with COVID-19 infection. A total of 304 patients were enrolled, of whom 108 had severe disease,… Continue Reading